Browse the corpus

Benazepril is an angiotensin-converting enzyme (ACE) inhibitor prescribed for hypertension management. Hypertension is a significant risk factor for cardiovascular morbidity and requires effective control. Understanding the FDA-approved indications, mechanism of action, and contraindications for benazepril is essential for healthcare professionals. Providers must also be aware of its adverse event profile, dosing, pharmacodynamics, pharmacokinetics, and monitoring requirements. Awareness of relevant drug-drug interactions, especially in patients with renal impairment or specific populations, enhances patient safety. Interprofessional collaboration among healthcare team members optimizes therapeutic outcomes when prescribing benazepril. Providing detailed information on benazepril supports the effective management of patients with hypertension and related conditions. Objectives: Identify the indications for initiating benazepril therapy. Determine benazepril's mechanism of action. Identify the potential side effects associated with benazepril therapy. Implement interprofessional team strategies for improving coordination and communication to improve outcomes for patients receiving benazepril therapy. Access free multiple choice questions on this topic.

There are no reports of renal failure in patients taking benazepril. The frequency of neutropenia and proteinuria were statistically insignificant compared to placebo during clinical trials. Compared to other ACE inhibitors, benazepril demonstrated a reduced rate of inducing systematic hypotension and the same rate of causing adverse drug reactions such as coughing, hyperkalemia, and serum creatinine elevation.[17] If benazepril ingestion is recent, clinicians can consider treatment with activated charcoal. Meanwhile, gastric decontamination (eg, vomiting, gastric lavage) should be considered if ingestion is recent. The patient's clinical symptoms and blood pressure should be closely monitored. Supportive management should be used to maintain systemic blood pressure and ensure adequate hydration. For patients with marked hypotension, the recommendation is to infuse physiological saline solution and, as needed, consider treatment with vasopressors (eg, intravenous catecholamines).

Increased systolic and diastolic blood pressure heightens cardiovascular risk, with the rise in absolute risk being more pronounced at higher blood pressure levels. Therefore, even slight decreases in blood pressure can yield significant benefits. While the relative risk reduction from lowering blood pressure remains consistent across different populations, the absolute benefits are more substantial for patients at higher risk, such as those with diabetes or hyperlipidemia. These patients likely benefit from more aggressive treatment to achieve lower blood pressure targets. Certain antihypertensive medications may have less pronounced effects on blood pressure when used as monotherapy in Black patients. Many antihypertensive drugs have other approved uses and benefits, such as managing angina, heart failure, or diabetic kidney disease. These factors help a clinician navigate therapy choices. Prescribers starting patients on benazepril for any indicated use should coordinate efforts with other interprofessional healthcare team members, including clinicians, mid-level practitioners, pharmacists, and nursing staff. Pharmacists should check for appropriate dosing, potential drug interactions, and contraindications. Nurses should assist with regular blood pressure checkups, ensure proper drug administration, and report abnormalities to the team. An interprofessional team approach is necessary when administering any medication, and benazepril is no exception; this increases the chances of therapeutic success and minimizes adverse drug reactions.